Veeva financial report Financial Outlook: Veeva is providing guidance for its fiscal fourth quarter ending January 31, Veeva excludes excess tax benefits for its internal management reporting processes. This annual research details the drivers, Veeva 2015 Paperless TMF Survey Annual Report 2 Usage of Paper and Digital Process Maturity The use of paper has declined in key functional areas. 1M, up 16% Year Over Year; Subscription Services Revenues of $402. The year-over-year estimates for clinical operations represent a significant drop – to less than a third (31%) managing most or all TMF documents on paper in 2015, down from 43% last year. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such Annual CRO Report The Veeva 2015 Paperless TMF Survey: Annual CRO Report explores the progress made by contract research organizations (CROs) toward paperless clinical trials through the experiences and opinions of CRO Trial Master File (TMF) owners from around the globe. Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, Veeva excludes excess tax benefits for its internal management reporting processes. The Veeva 2020 Unified Clinical Operations Survey Report examines the life sciences industry’s progress toward modernizing clinical operations by gathering the experiences and opinions of more than 500 clinical operations professionals from around the globe. (VEEV) financial report provides detailed insights into these operations and their financial impact, Veeva Systems Inc. Customer success. The Veeva Systems Inc. The report highlights significant financial growth, strategic initiatives aimed at expanding product offerings, a Discover in-depth financial reports, analysis, and insights for VEEVA SYSTEMS INC on SECsense. * Powered By Q4 Inc. EPS came in at $1. Annual Revenue Growth: Veeva Systems Inc reported a 10% increase in total revenues, reaching $2,363. 5 million, while non-GAAP operating income rose by 7% to $234. Veeva 2015 Paperless TMF Survey Annual Report 2 Usage of Paper and Digital Process Maturity The use of paper has declined in key functional areas. What: Veeva Systems Fiscal 2022 Third Quarter Resul ts Conference Call When: Wednesday, December 1, 2021 Interactive Chart for Veeva Systems Inc. During these check-ins the manager and employee discuss Veeva Systems Inc. ) 4280 Hacienda Drive Pleasanton, California, 94588 Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance, provided as of August 28, 2024, about Veeva's expected future financial results. The aggregate market value of voting stock held by non-affiliates of the Registrant on the last business day of the Registrant’s most recently completed second fiscal quarter, w Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotes from management and guidance provided as of March 1, 2023 about Veeva's expected future financial results. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance provided as of June 1, 2022 about Veeva's expected future financial results. Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2022, after market close on December 1, 2022. The Veeva 2019 Unified Clinical Operations Survey Report: Annual CRO Report examines contract research organizations’ (CROs) progress toward a unified clinical operating environment by gathering the experiences and opinions of CRO respondents from around the world. Veeva management also finds it useful to exclude excess tax benefits when assessing the level of cash provided by operating activities. The Veeva Pulse Field Trends Report is a quarterly industry benchmark for global and regional healthcare professional (HCP) engagement across the life sciences industry. PLEASANTON, CA — June 8, 2020 — Veeva Systems (NYSE:VEEV) today announced that Brent Bowman will become the company’s next chief financial officer. The Veeva Pulse Field Trends Report delivers insights that inform the industry and help field teams align their We report against our PBC obligations annually and publicly. Tender Offer/Acquisition Reports . Washington, D. “Veeva passed the billion-dollar annual Veeva Pulse data is sourced from Veeva’s aggregated CRM activity dataset, inclusive of field engagement stats from all instances of Veeva CRM globally. More than a third (42%) now use an eTMF application, double the number reported in 2014. ; Non-GAAP fully diluted net income per share between $1. PDF format download (opens in new window) Excel format download (opens in new window) XBRL format download (opens in new window) Gunnar Hansen ir@veeva. 21 million, up 13. 20549 _____ FORM 10-K _____ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ended January 31, 2021 Veeva Systems Inc (VEEV) - Financial and Strategic SWOT Analysis Review Veeva Systems Inc (VEEV) - Financial and Strategic SWOT Analysis Review - provides you an - Market research report and industry analysis - 36994470 The latest financial ratios derived from the annual financial statements published by the company with 5 years history. We are furnishing this Proxy Statement in connection with the solicitation of proxies by the Board of Directors (the ''Board'') of Veeva Systems Inc. Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotations of management and guidance provided as of March 2, 2022 about Veeva's expected future financial results. PT today, December 1, 2021, and a replay of the call will be available on Veeva's investor relations website. 2% from the December 15th total of 2,020,000 shares. It 2021 Annual Report & Proxy Statement (PDF 987 KB) 2020: 2020 Annual Report & Proxy Statement (PDF 769 KB) 2019: 2019 Annual Report & Proxy Statement (PDF 2. Read the latest findings in the Veeva 2016 Paperless TMF Survey: Annual Report, the industry's largest, annual global survey of TMF owners. See the section titled “Non-GAAP Financial Measures” and the tables entitled “Reconciliation of GAAP to Non Total Revenues of $505. API Tools. Cl A balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. One year ago, theory started to become reality: asked to rank which initiatives have the highest potential value and likelihood of success over the next two years, clinical leaders ranked data science second Warning! GuruFocus has detected 6 Warning Sign with VEEV. 5 days. EPS of $1. com . 6% year on year. 90 a Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotations of management and guidance provided as of March 2, 2022 about Veeva’s expected future financial results. The responses in this report were collected as part of the larger For more information, and to obtain copies of this annual report and proxy statement free of charge, write to us at Corporate Secretary, Veeva Systems Inc. Discover in-depth financial reports, analysis, and insights for VEEVA SYSTEMS INC on SECsense. Veeva Systems Inc (VEEV) 10-K Annual Report Wed Mar 30 Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance, provided as of December 6, 2023, about Veeva's expected future financial results. In this year's report, you will read about: How different eTMF solutions impact inspection readiness and accessibility; What capabilities sponsors consider key to going paperless B. Enter. Auditor Independence and Qualifications Financial Outlook: Veeva is providing guidance for its fiscal third quarter ending October 31, Veeva excludes excess tax benefits for its internal management reporting processes. Bowman will assume the role of CFO after a transition period of approximately 90 days with current CFO Tim Cabral, Total Revenues of $266. • Non-GAAP fully diluted net A study is prompted to be selected when running TMF Completeness by Milestones report. 1% from the 2024 Annual Meeting of Shareholders: June 12, 2024 at 9:00 AM Pacific Time. 6 Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2021 as follows: • Total revenues between $450 and $452 million. engages in the provision of industry cloud solutions for the global life sciences industry. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. Clinical data management evolves into clinical data science. Here’s what investors should know. Recent Disclosures; Contact IR; FAQs; Email Alerts; 08. Pricing. Veeva Systems (VEEV) Historical Annual Reports 2014-2024 financial accounting standards provided pursuant to Section 13(a) Ten years of annual and quarterly financial statements and annual report data for Veeva Systems (VEEV). , a leading provider of industry cloud solutions for the global life sciences industry, has released its financial results for the third quarter of fiscal 2025, ending October 31, 2024. Webcast (opens in new window) 2024 Annual Report & Proxy Statement (opens in new window) ir@veeva. 7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. 3M, up 28% Year-over-year Veeva Systems Inc. Veeva Customers can get answers to common issues or problems, participate in the Product Communities, submit product enhancement requests, and submit tickets to Veeva Product Support. 25. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2022. Form 8-K. Based on an average trading volume of 1,090,000 shares, the days-to-cover ratio is presently 2. Cl A annual income statement. 39 million in revenue for the quarter ended January 2023, representing a year-over-year increase of 16%. Estimating guidance accurately for future periods is difficult. Root Cause: Missing a report filter that Milestone has at least one Expected Document. Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance provided as of February 29, 2024 about Veeva's expected future financial results. This overview will introduce you to the core capabilities of Vault Reporting and Dashboards and will provide links to helpful additional content if you would like to learn more. Healthcare software provider Veeva Systems (NASDAQ:VEEV) will be reporting earnings tomorrow after the bell. Proxy Statements . Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2021 as follows: This release contains forward-looking statements, including the quotations from management, the statements in “Financial Outlook,” and other statements regarding Veeva’s future performance, outlook, and guidance and the Veeva Systems Inc. An investor presentation providing additional information and analysis can be found at ir. Periodic Financial Reports . • Non-GAAP operating income between $265 and $267 million(3). Non-GAAP operating Financial Outlook: Veeva is providing guidance for its fiscal fourth quarter ending January 31, Veeva excludes excess tax benefits for its internal management reporting processes. Email * Mailing Lists Veeva Systems Inc (VEEV) SEC Filing 10-K Annual report for the fiscal year ending Friday, January 31, 2020. Veeva 2018 Unified Clinical Operations Survey: Annual CRO Report 3 Top Drivers for Unified Clinical Operations Base: Total respondents, N=180 To the degree your organization needs to better integrate/unify the clinical applications identified in question 3 (e. Annual & Proxy; SEC Filings; Governance; Resources. 21. ET) to discuss its financial results. Annual CRO Report The Veeva 2015 Paperless TMF Survey: Annual CRO Report explores the progress made by contract research organizations (CROs) toward paperless clinical trials through the experiences and opinions of CRO Trial Master File (TMF) owners from around the globe. HOWCANIVOTE: Shareholdersofrecordcanvoteinanyoftheseways: • Internet:www. Three years ago, it was predicted that clinical data science would one day emerge from clinical data management. 00 and set a "hold" rating for the company in a research report on Monday. See the section titled “Non-GAAP Financial Measures” and the tables entitled “Reconciliation of GAAP to Non Our latest Veeva Systems Inc. 7 million for the fiscal year 2024. The company’s shares closed last Friday at $199. First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Analysts Have Made A Financial Statement On Veeva Systems Inc. Index Articles Forex Financial Ratios Crypto Financial Analysis Other. WearefurnishingthisProxyStatementinconnectionwith Veeva is providing guidance for its fiscal third quarter ending October 31, 2024 as follows: Total revenues between $682 and $685 million. Veeva’s management also finds it useful to exclude these expenses when they assess the appropriate level of PLEASANTON, CA — March 3, 2020 — Veeva Systems Inc. 07 and $1. During these check-ins the manager and employee discuss Veeva 2017 Clinical Operations Survey Annual CRO Report 2 • Consistent with the drive to streamline collaboration and implement end-to-end processes, CROs are moving away from manual systems. Veeva will host a conference call and webcast that day at 2:00 p. Report Types determine which objects and combinations of Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotes from management and guidance, provided as of December 6, 2023, about Veeva’s expected future financial results. Bowman brings more than 25 years of technology industry expertise to Veeva Veeva Systems (NYSE: VEEV) today announced that Brent Bowman will become the company’s next chief financial officer. Subscription Services Surge: Subscription services revenues Veeva Systems Inc (VEEV) SEC Filing 10-K Annual Report for the fiscal year ending Tuesday, January 31, 2023. "It was a great quarter of innovation and deepening on Veeva's investor relations website at ir. Veeva Systems Inc reports have an aggregate usefulness score of 4. proxyvote. PT (5:00 p. - 10K - Annual Report - March 30, 2023; Table of Contents. The annual research details the drivers Annual & Proxy; SEC Filings; Governance; Resources. This annual research details the drivers, barriers, WHAT: 2021 Annual Meeting of Shareholders. . 34 in the year-ago quarter. Non-GAAP obtain copies of this annual report and proxy statement free of charge, write to us at Corporate Secretary, Veeva Systems Inc. Veeva Systems Inc (VEEV) SEC Filing 10-K Annual report for the fiscal year ending Sunday, January 31, 2021. Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotations of management and guidance provided as of March 2, 2022 about Veeva's expected future financial results. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal second quarter ended July 31, 2019. Market News. The following summary presents key analysts, their recent evaluations, and adjustments to ratings Veeva Systems Inc. The annual research details the drivers, barriers, Veeva OpenData Clinical Accurate site and The Veeva 2020 Unified Clinical Operations Survey Report examines the life sciences industry’s progress toward modernizing clinical operations by gathering the experiences and opinions of more than 500 clinical operations professionals from around the globe. Navigating 2025: Key Clinical Operations Strategies for Emerging Biotechs Download PDF The Evolving Clinical Operations Landscape in Emerging Biotechs As the life sciences industry continues to evolve, emerging biotechs face unprecedented challenges and opportunities with changing regulatory guidance, rapid shifts in investment strategies, and new technologies. (1) This press release uses non-GAAP financial metrics that are adjusted for the impact of various GAAP items. Annual Financial Statements and Disclosures (a) The Committee will meet to review and discuss with the independent auditor and the Company’s management the Company’s annual audited financial statements and annual report on Form 10-K, including the Company’s specific disclosures under Veeva Systems Inc. In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on Veeva Systems (VEEV – Research Report). API Documentation. Email * Financial Outlook: Veeva is providing guidance for its fiscal first quarter ending April 30, 2021 as follows: “Financial Outlook,” and other statements regarding Veeva’s future performance, outlook, and guidance and the assumptions underlying those statements, market growth, the benefits from the use of Veeva’s solutions, our ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) 001-36121 _____ Veeva Systems Inc. View VEEV financial statements in full, including balance sheets and ratios. 02. NOTICE OF 2022 ANNUAL MEETING OF SHAREHOLDERS WHAT:2022AnnualMeetingofShareholders. veeva. Previous Annual Reports and Proxies Files on this page are PDF. Merit Financial Group LLC grew its stake in Veeva Systems Inc. 62 for the second quarter of fiscal 2025, which increased 33. Financial Outlook: Veeva is providing guidance for its fiscal first quarter compensation expenses primarily because they are non-cash expenses that Veeva excludes from its internal management reporting processes. (2) Veeva is not able, at this time, to provide GAAP targets for operating income and fully diluted net income per share for the third fiscal quarter ending October 31, 2023, the fiscal year ending January 31, 2024, or the fiscal year ending January 31, 2025, because of the difficulty of estimating certain items excluded from non -GAAP operating income and Veeva (VEEV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 2 million, up 14. Vault admins have the ability to create Report Types within Admin > Configuration > Report Types. Veeva Systems >Annual Reports >2022 Annual Report Veeva Systems Annual Report 2022 Form 10-K (NYSE:VEEV) Published: March 30th, 2022 Brought to you by . 08 (2). Form 4. com. , a leading provider of cloud-based software solutions for the global life sciences industry, has released its Form 10-Q report for the quarter ended October 31, 2024. Veeva Systems Inc. (VEEV), analyze all the data with a huge range of indicators. comuntil11:59p. 00 in a research note issued to investors on Veeva Systems Inc. Financial Outlook: Veeva is providing guidance for its fiscal first quarter ending April 30, Veeva excludes excess tax benefits for its internal management reporting processes. Veeva Systems Inc (VEEV) SEC Filing 10-K Annual Report for the fiscal year ending Monday, January 31, 2022. provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. SECURITIES AND EXCHANGE COMMISSION. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal third quarter ended October 31, 2020. We were founded in 2007 on the premise that industry- We report against our PBC obligations annually and publicly. ; Veeva is providing updated guidance for its fiscal year ending January 31, 2023 as follows: Veeva’s Financial Profile:, Investors: 1. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal fourth quarter ended January 31, 2020. g. 75, compared to $1. , 4280 Hacienda Drive, Pleasanton, California 94588, USA; phone us at +1-925-452-6500; or visit our website at www. 9M, up 27% Year-over-year; Subscription Services Revenues of $217. PLEASANTON, CA — December 1, 2020 — Veeva Systems Inc. m. Healthcare software provider Veeva Systems (NASDAQ:VEEV) will be reporting earnings tomorrow after market close. • Non-GAAP operating income between $175 and $177 million(2). How To. PDF format download (opens in new window) Excel format download (opens in new window) Investor Contact. Find out the revenue, expenses and profit or loss over the last fiscal year. Explore Last Report 12/05/2024 : Fiscal Yr Veeva Systems Inc demonstrated solid financial growth in the third quarter. Get the detailed quarterly/annual income statement for Veeva Systems Inc. The institutional investor owned 37,810 shares of the technology company's stock after buying an additional 1,687 shares during the quarter. The optimism, led by a solid third-quarter fiscal 2025 performance and strategic Investor Presentation Details. Veeva Systems (VEEV) reported $563. 6M, up 18% Year Over Year Veeva Systems Inc. Annual CRO Report The Veeva 2020 Unified Clinical Operations Survey: Annual CRO Report examines contract research organizations’ (CROs) progress toward modernizing clinical operations by gathering the experiences and opinions of CRO respondents around the globe. “We founded Veeva 15 years ago with a clear vision of the industry cloud for life sciences,” said CEO Peter Gassner. 2021. • Non-GAAP fully diluted net A Leader in Cloud-Based Software for the Global Life Sciences Industry Innovation. Here's what to expect. 33 MB) 2018: ir@veeva. WearefurnishingthisProxyStatementinconnectionwith Veeva Systems Inc. Income statements, balance sheets, cash flow statements and key ratios. Operating income increased by 6% year over year to $128. June 12, 2024 09:00 PST. 5 million, up 34% Year-over-year; Subscription Services Revenues of $302. , a public benefit corporation under the laws of the State of Delaware, for use at the 2021 Annual Meeting of Shareholders (the ''Annual Meeting'') described here. 8 based on 165 reviews. (VEEV). Statement of Changes in Beneficial Ownership. com approximately at 1:05 PLEASANTON, Calif. The company reported strong performance across various financial metrics, reflecting its contin Veeva Systems Q2 Earnings & Revenues Beat, Operating Margin Up Y/Y Veeva Systems reported adjusted earnings per share of $1. However, the results of the report are not limited to the selected study but also include other studies' records. Veeva Systems Inc (VEEV) 10-K Annual Report Tue Mar 30 2021; The findings are based on approximately 600 million annual global field activities captured in Veeva CRM and Veeva CRM Engage. 2024 Veeva Public Benefit Corporation Report Operating as a Public Benefit Corporation As a Public Benefit Corporation, we are guided by our core values — do the right thing, customer success, employee success, and speed — to help the life sciences industry improve health and extend life and to create high-quality jobs that benefit our employees and communities. Email Alerts. View VEEV financial statements in full. A Leader in Cloud-Based Software for the Global Life Sciences Industry Innovation. Veeva Systems beat analysts’ revenue expectations by 1. (NYSE:VEEV - Get Free Report) saw a large increase in short interest in December. Veeva CRM also had 15 new SMB wins, enterprise expansions, and strength internationally with two major field forces in Asia standardizing on the product. As a Public Benefit Corporation, we are guided by our core values — do the right thing, customer success, employee success, and speed — to help the life sciences industry improve health and extend life and to create high-quality jobs that benefit our employees and communities. Veeva Systems Inc (VEEV) SEC Filing 10-K Annual Report for the fiscal year ending Tuesday, January 31, 2023. Non-GAAP operating income between NOTICE OF 2023 ANNUAL MEETING OF SHAREHOLDERS WHAT:2023AnnualMeetingofShareholders. Non-GAAP operating income between $209 and $211 million (2). Blog. 2. • Non-GAAP fully diluted net Total Revenues of $377. As of December 31st, there was short interest totalling 2,710,000 shares, an increase of 34. Veeva Systems Inc (VEEV) 10-K Annual Report Mon Mar 30 2020; SEC Veeva 2015 Paperless TMF Survey Annual Report 2 Usage of Paper and Digital Process Maturity The use of paper has declined in key functional areas. Education. Veeva Systems (NYSE:VEEV) Will Want To Turn Around Its Return Investor Presentation Details. On February 29, 2024, Veeva Systems Inc released its 8-K filing, detailing the financial results for the fourth quarter and the fiscal Introduction: Vault Reporting and Dashboards allow you to track, analyze and visualize your global data. Veeva is building momentum for the large opportunity ahead, with more than 275 customers now using both Vault QualityDocs and Vault QMS, including 10 of the top 20 pharmas. , 4280 Hacienda Drive, Pleasanton, California 94588, USA; Veeva is providing guidance for its fiscal second quarter ending July 31, 2024 as follows: Total revenues between $666 and $669 million. A month has gone by since the last earnings report for Veeva Systems (VEEV). Here’s what investors should know. Veeva will host a Q&A conference call at 2:00 p. , CTMS, EDC, The Veeva 2019 Unified Clinical Operations Survey Report: Annual CRO Report examines contract research organizations’ (CROs) progress toward a unified clinical operating environment by gathering the experiences and opinions of CRO respondents from around the world. 9 million, up 34% Year-over-year. The annual research details the drivers, barriers, and benefits of a unified clinical Veeva 2015 Paperless TMF Survey Annual Report 2 Usage of Paper and Digital Process Maturity The use of paper has declined in key functional areas. UNITED STATES. Total Funding: $258M. 4% over the same period last year. Click the button below to request a report when Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2023 as follows: Total revenues between $580 and $582 million. We believe in transparency and the value of formalizing commitments by writing them down and communicating clearly. Bowman will assume the role of CFO after a transition period of approximately 90 days with current CFO Tim Cabral, Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2023, after market close on March 1, 2023. It involves Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotes from management and guidance, provided as of December 6, 2023, about Veeva’s expected future financial results. Acquire key Veeva has recently released 2024 Q2 report with the following insight: Veeva calls out litigation risks related to ongoing legal disputes with competitors, management and the firm regarding financial reporting) for the purpose of preparing or issuing an audit report or performing other audit, review, or attest services for the Company, and the independent auditor and each such registered public accounting firm will report directly to the Committee. View the latest VEEV financial statements, income statements and financial ratios. C. In addition, this study used marketing effectiveness Veeva Systems Inc (VEEV) SEC Filing 10-K Annual report for the fiscal year ending Sunday, January 31, 2021. Shares have lost about 3. This report also includes insights from Veeva Pulse Content Metrics, the first and only industry benchmark for commercial content performance based on real-world, anonymized data collected across 350+ global pharma Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2024 as follows: • Total revenues between $666 and $669 million. , March 2, 2022 – Veeva Systems Inc. Acquisitions: 2. Veeva is providing guidance for its fiscal third quarter ending October 31, 2022 as follows: Total revenues between $545 and $547 million. 2024. HOME; LOGIN; LATE CORPORATE NEWS . The report is based on approximately 600 million annual global field activities captured in Veeva CRM and Veeva CRM Engage. (Get Free Report) Veeva Systems Inc provides cloud-based software for the life sciences industry. Bowman will assume the role of CFO after a transition period of approximately 90 days with current CFO Tim Cabral, who previously announced his intent to Veeva Systems, Inc. Home. Bowman brings more than 25 years of technology industry expertise to Veeva. 15 for the same period compares to $0. 's (NYSE:VEEV) Second-Quarter Report Sep 07. All results in the current period and guidance reflect the impact from our recently acquired businesses. 2% last quarter, reporting revenues of $676. AI-powered financial report analysis platform. Veeva will post prepared remarks to its investor relations website at The perception of Veeva Systems by financial experts is analyzed through recent analyst actions. (VEEV) stock quote, history, news and other vital information to help you with your stock trading and investing. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end Veeva Systems Inc. copies of this annual report and proxy statement free of charge, write to us at Corporate Secretary, Veeva Systems Inc. Veeva will post prepared remarks to its investor relations website at https://ir. Financial Outlook: Veeva is providing guidance for its fiscal fourth quarter ending January 31, 2022 as follows: Total revenues between $478 and $480 million. API Viewer. Product excellence. (Exact name of registrant as specified in its charter) _____ Delaware 20-8235463 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No. 90 a 2. - 10K - Annual Report - March 30, 2021; Table of Contents. Financial Outlook: Veeva is providing guidance for its fiscal fourth quarter ending January 31, 2025 as follows: Total revenues between $696 and $699 million. Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance provided as of June 1, 2022 about Veeva's expected future financial results. Gunnar Hansen ir@veeva. Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2023 as follows: Total revenues between $580 and $582 million. Funding Rounds: 4. Its solutions include Veeva CRM, a customer relationship management solution Financial Outlook: Veeva is providing guidance for its fiscal second quarter ending July 31, 2023 as follows: • Total revenues between $580 and $582 million. Non-GAAP operating income between Financial Outlook: Veeva is providing guidance for its fiscal first quarter ending April 30, 2023 as follows: • Total revenues between $514 and $516 million. Current report filing. 20549 _____ FORM 10-K _____ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ended January 31, 2023 The aggregate market value of voting stock held by non-affiliates of the Registrant on the last business day of the Registrant’s most recently completed second fiscal quarter, w Forward-looking Statements This release contains forward-looking statements regarding Veeva’s expected future performance and, in particular, includes quotes from management and guidance, provided as of May 30, 2024, about Veeva’s expected future financial results. Cl A Annual stock financials by MarketWatch. to Report Q2, 2025 Results on Aug 28, 2024 Aug 08. Managers at Veeva conduct a bi-annual check-in with each team member to foster trust and open communication. Truist Financial lowered their price objective on Veeva Systems from $261. provides cloud-based software for the life sciences industry. Veeva Systems Inc (VEEV) SEC Filing 10-K Annual report for the fiscal year ending Friday, January 31, 2020. WearefurnishingthisProxyStatementinconnectionwith Financial Outlook: Veeva is providing guidance for its fiscal fourth quarter ending January 31, Veeva excludes excess tax benefits for its internal management reporting processes. Email * Mailing Lists * PR: SEC: Events : Enter the code shown above. Veeva Systems Inc (VEEV) 10-K Annual Report Thu Mar 30 obtain copies of this annual report and proxy statement free of charge, write to us at Corporate Secretary, Veeva Systems Inc. SEC Filings. Stay updated with the latest articles and market trends. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2022. EasternTimeonTuesday,June22,2021; • Telephone:1-800-690 Veeva Systems (NYSE:VEEV – Get Free Report) had its price objective decreased by equities research analysts at Truist Financial from $261. Find the latest Veeva Systems Inc. The responses in this report were collected as part of the larger Veeva 2015 Paperless TMF Survey Annual Report 2 Usage of Paper and Digital Process Maturity The use of paper has declined in key functional areas. Bowman will assume the role of CFO after a transition period of approximately 90 days with current CFO Tim Cabral, who previously announced his intent to Forward-looking Statements This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance, provided as of August 28, 2024, about Veeva's expected future financial results. Download Acrobat Reader free of charge. (NYSE:VEEV - Free Report) by 4. Recent Disclosures; Contact IR; FAQs; Email Alerts; 03. Veeva Systems Inc does not currently have any hardcopy reports on AnnualReports. ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2020 OR Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Solution: Stock Story - Healthcare software provider Veeva Systems (NASDAQ:NYSE: VEEV) will be reporting earnings tomorrow after the bell. 5% in that time frame, underperforming the S&P 500. For the quarter ended October 2024, Veeva Systems (VEEV) reported revenue of $699. • Non-GAAP operating income between $199 and $201 million (2). Financial Statements and Disclosures 1. provides cl FMP. 00 to $210.